Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors ; volume:36 ; number:02 ; year:2015 ; pages:99-104
Indian journal of medical & paediatric oncology ; 36, Heft 02 (2015), 99-104
- Beteiligte Personen und Organisationen
-
Mallick, Supriya
Gandhi, Ajeet Kumar
Joshi, Nikhil P.
Kumar, Anupam
Puri, Tarun
Sharma, Daya Nand
Haresh, Kunhi Parambath
Gupta, Subhash
Julka, Pramod Kumar
Rath, Goura Kisor
Sarkar, Chitra
- DOI
-
10.4103/0971-5851.158838
- URN
-
urn:nbn:de:101:1-2021083009582028715327
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mallick, Supriya
- Gandhi, Ajeet Kumar
- Joshi, Nikhil P.
- Kumar, Anupam
- Puri, Tarun
- Sharma, Daya Nand
- Haresh, Kunhi Parambath
- Gupta, Subhash
- Julka, Pramod Kumar
- Rath, Goura Kisor
- Sarkar, Chitra
Ähnliche Objekte (12)
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
A Prospective Randomized Comparison of Concurrent Chemoradiation with Neoadjuvant and Adjuvant Chemotherapy with Concurrent Chemoradiation Alone for Locally Advanced Carcinoma Cervix
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single‑center Data
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
A Prospective Randomized Comparison of Concurrent Chemoradiation with Neoadjuvant and Adjuvant Chemotherapy with Concurrent Chemoradiation Alone for Locally Advanced Carcinoma Cervix
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single‑center Data
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
A Prospective Randomized Comparison of Concurrent Chemoradiation with Neoadjuvant and Adjuvant Chemotherapy with Concurrent Chemoradiation Alone for Locally Advanced Carcinoma Cervix
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single‑center Data